Protection against experimental allergic encephalomyelitis.

Suppr

超能文献

作者信息

Teitelbaum D, Webb C, Meshorer A, Arnon R, Sela M

出版信息

Nature. 1972 Dec 29;240(5383):564-6. doi: 10.1038/240564b0.

DOI:10.1038/240564b0

PMID:4119624

Abstract

摘要

相似文献

Protection against experimental allergic encephalomyelitis.

Nature. 1972 Dec 29;240(5383):564-6. doi: 10.1038/240564b0.

Suppression of experimental allergic encephalomyelitis by a synthetic polypeptide.一种合成多肽对实验性变应性脑脊髓炎的抑制作用

Eur J Immunol. 1971 Aug;1(4):242-8. doi: 10.1002/eji.1830010406.

Oral tolerance in experimental autoimmune encephalomyelitis: specificity of peptide-induced oral tolerance.实验性自身免疫性脑脊髓炎中的口服耐受：肽诱导口服耐受的特异性。

Ann N Y Acad Sci. 1996 Feb 13;778:393-4. doi: 10.1111/j.1749-6632.1996.tb21154.x.

Suppression of experimental allergic encephalomyelitis in Rhesus monkeys by a synthetic basic copolymer.一种合成碱性共聚物对恒河猴实验性变应性脑脊髓炎的抑制作用

Clin Immunol Immunopathol. 1974 Nov;3(2):256-62. doi: 10.1016/0090-1229(74)90012-9.

Complete Freund's adjuvant-induced immune prevention against experimental allergic encephalomyelitis in guinea pigs: early appearance of anti-myelin basic protein antibody.完全弗氏佐剂诱导的豚鼠实验性变态反应性脑脊髓炎的免疫预防：抗髓鞘碱性蛋白抗体的早期出现

Jpn J Exp Med. 1981 Apr;51(2):137-9.

Immune protection against experimental autoimmune encephalomyelitis: optimal conditions and analysis of mechanism.

Cell Immunol. 1974 Jun;12(3):370-81. doi: 10.1016/0008-8749(74)90093-8.

The effect of Cop 1, a synthetic polypeptide, on chronic relapsing experimental allergic encephalomyelitis in guinea pigs.合成多肽Cop 1对豚鼠慢性复发性实验性变应性脑脊髓炎的作用。

J Neurol Sci. 1979 Jul;42(2):267-74. doi: 10.1016/0022-510x(79)90058-3.

In vitro response to basic protein in experimental allergic encephalomyelitis: effect of pretreatment with basic protein in incomplete adjuvant.实验性变应性脑脊髓炎中对碱性蛋白的体外反应：用不完全佐剂中的碱性蛋白预处理的效果

Cell Immunol. 1980 Jul 1;52(2):443-50. doi: 10.1016/0008-8749(80)90365-2.

Durability of immune protection against experimental autoimmune encephalomyelitis.

Cell Immunol. 1976 Mar 15;22(2):297-310. doi: 10.1016/0008-8749(76)90031-9.

Experimental allergic encephalomyelitis in guinea pigs. Influence of thymosin fraction V on the disease.豚鼠实验性变应性脑脊髓炎。胸腺素组分V对该病的影响。

J Neuroimmunol. 1985 Jan;7(4):215-9.

引用本文的文献

Cytokine Signaling in Multiple Sclerosis and Its Therapeutic Applications.细胞因子信号传导在多发性硬化症中的作用及其治疗应用

Med Sci (Basel). 2017 Oct 13;5(4):23. doi: 10.3390/medsci5040023.

A Journey in Science: The Privilege of Exploring the Brain and the Immune System.科学之旅：探索大脑与免疫系统的特权

Mol Med. 2016 Jun 2;22:99-114. doi: 10.2119/molmed.2015.00263.

Translational research in neurology and neuroscience 2010: multiple sclerosis.2010年神经病学与神经科学领域的转化研究：多发性硬化症

Arch Neurol. 2010 Nov;67(11):1307-15. doi: 10.1001/archneurol.2010.158. Epub 2010 Jul 12.

B-cell delivered gene therapy for tolerance induction: role of autoantigen-specific B cells.B 细胞介导的基因治疗诱导耐受：自身抗原特异性 B 细胞的作用。

J Autoimmun. 2010 Sep;35(2):107-13. doi: 10.1016/j.jaut.2010.05.002. Epub 2010 Jul 1.

What do we know about the mechanism of action of disease-modifying treatments in MS?我们对多发性硬化症中疾病修饰治疗的作用机制了解多少？

J Neurol. 2004 Sep;251 Suppl 5:v12-v29. doi: 10.1007/s00415-004-1504-y.

Risk-benefit assessment of glatiramer acetate in multiple sclerosis.醋酸格拉替雷治疗多发性硬化症的风险效益评估。

Drug Saf. 2001;24(13):979-90. doi: 10.2165/00002018-200124130-00005.

Failure of myelin basic protein to prevent or suppress experimental allergic encephalomyelitis in guinea pigs.髓磷脂碱性蛋白无法预防或抑制豚鼠实验性变应性脑脊髓炎。

Neurochem Res. 1980 Feb;5(2):101-13. doi: 10.1007/BF00964325.

Failure of basic protein therapy for multiple sclerosis.

J Neurol. 1977 Aug 18;216(1):27-31. doi: 10.1007/BF00312812.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验